Drug Shortage Report for ADACEL
| Report ID | 280445 |
| Drug Identification Number | 02240255 |
| Brand name | ADACEL |
| Common or Proper name | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed |
| Company Name | SANOFI VACCINES CANADA LTD. |
| Market Status | MARKETED |
| Active Ingredient(s) | TETANUS TOXOID FIMBRIAE TYPES 2 AND 3 PERTACTIN FILAMENTOUS HAEMAGGLUTININ DIPHTHERIA TOXOID PERTUSSIS TOXOID |
| Strength(s) | 5LF 5MCG 3MCG 5MCG 2LF 2.5MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10 x 0.5 mL vials |
| Anatomical Therapeutical Chemical (ATC) code | J07AJ |
| Anatomical Therapeutical Chemical (ATC) description | BACTERIAL VACCINES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2026-03-10 |
| Actual start date | 2026-03-10 |
| Estimated end date | 2026-04-24 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-12 |
| Company comments | A supplier has identified a defect potentially impacting batches of Adacel intended for release to the Canadian market. Sanofi is working to resolve the situation as soon as possible, and identify options to mitigate any potential impact. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
| Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-12 | French | Compare |
| v1 | 2026-03-12 | English | Compare |
Showing 1 to 2 of 2